Skip to main content
. 2011 May 1;11(9):812–815. doi: 10.4161/cbt.11.9.15178

Table 1.

Patient and disease characteristics

No. (%)
Age (years)
Median (range) 51 (27–75%)
Histology
Infiltrating ductal carcinoma 11 (92%)
Infiltrating lobular carcinoma 0 (0%)
Other 1 (8%)
Estrogen receptor status
Positive 10 (83%)
Negative 2 (17%)
HER2 status
Amplified 1 (8%)
Normal 11 (92%)
Tumor size (pT)
pT1 7 (58%)
pT2–pT4 5 (42%)
Nodal status
Positive 5 (42%)
Negative 7 (58%)
Neoadjuvant chemotherapy
Yes 5 (42%)
No 7 (58%)